Sign in to our library of over $5 million worth of researchclose

Two Quick Steps

* Required Fields

Click Your Industry



Registered Customers

If you have an account with us, please log in.

* Required Fields



Subscribe today
Sign in to our library of over $5 million worth of researchclose

Two Quick Steps

* Required Fields

Click Your Industry



Registered Customers

If you have an account with us, please log in.

* Required Fields



Subscribe today

We deliver Mobile Wallet Market Research and SWOT Analysis from Alternative Energy to Pharmaceuticals and Healthcare Market Research Reports to Digital Media.

Skip to Main Content »

Search Site
Researchers Currently Online:1942

Benitec Biopharma Limited (BLT) - Financial and Strategic SWOT Analysis Review

Benitec Biopharma Limited (BLT) - Financial and Strategic SWOT Analysis Review

Double click on above image to view full picture

Zoom Out
Zoom In
Additional Information
Price $125.00
Meta Description Benitec Biopharma Limited (Benitec), formerly Benitec Limited, is a research focused biotechnology company. The company is indulged in the development of novel therapeutics for the treatment of chronic and life threatening diseases based on its proprietar
Publisher GlobalData
Date of Report Dec 3, 2013
Quick Overview
Summary

Benitec Biopharma Limited (Benitec), formerly Benitec Limited, is a research focused biotechnology company. The company is indulged in the development of novel therapeutics for the treatment of chronic and life threatening diseases based on its proprietary gene silencing DNA directed RNA interference (ddRNAi) technology. The company operates in a single business segment which is global commercialization of all the patents and licenses developed in the area of functional genomics with their applications in biomedical research and human therapeutics.

Benitec Biopharma Limited Key Recent Developments

Oct 08, 2012: Benitec Biopharma Receives Notice Of Allowance For RNAi Expression Constructs In ChinanFeb 28, 2012: Benitec Biopharma Reports H1 Fiscal 2012 Results
Feb 06, 2012: Benitec Biopharma And Medistem Technologies Announce Successful Treatment Of Rheumatoid Arthritis In Preclinical Studies
Jan 09, 2012: Researchers Demonstrate Potential Of Benitec's ddRNAi Technology To Develop Revolutionary Therapeutics From Single AdministrationGDPH61680FSA

This comprehensive SWOT profile of Benitec Biopharma Limited provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Section 1 - About the Company 5
Benitec Biopharma Limited - Key Facts 5
Benitec Biopharma Limited - Key Employees 6
Benitec Biopharma Limited - Key Employee Biographies 7
Benitec Biopharma Limited - Major Products and Services 8
Benitec Biopharma Limited - Pharmaceutical Pipeline Products Data 9
Benitec Biopharma Limited, Pipeline Products by Therapy Area 9
Benitec Biopharma Limited, Pipeline Products by Development Phase 10
Benitec Biopharma Limited - History 12
Benitec Biopharma Limited - Company Statement 15
Benitec Biopharma Limited - Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Section 2 – Company Analysis 18
Benitec Biopharma Limited - Business Description 18
Benitec Biopharma Limited - Corporate Strategy 20
Benitec Biopharma Limited - SWOT Analysis 21
SWOT Analysis - Overview 21
Benitec Biopharma Limited - Strengths 21
Strength - Technological Capabilities 21
Strength - Intellectual Property Portfolio 21
Strength - Licensing Partnerships 21
Benitec Biopharma Limited - Weaknesses 21
Weakness - Issues Related to Patent Estate 21
Weakness - History of Losses 22
Benitec Biopharma Limited - Opportunities 22
Opportunity - Key Business Initiatives 22
Opportunity - Market Potential: RNA interference 22
Opportunity - Growth Prospects: Oncology 22
Benitec Biopharma Limited - Threats 23
Threat - Highly Competitive Industry 23
Threat - Uncertainties in R&D 23
Threat - Industry Regulations 23
Benitec Biopharma Limited - Key Competitors 24
Section 3 – Company Financial Ratios 25
Financial Ratios - Capital Market Ratios 25
Financial Ratios - Annual Ratios 25
Performance Chart 27
Financial Performance 27
Financial Ratios - Interim Ratios 28
Financial Ratios - Ratio Charts 29
Section 4 – Company’s Lifesciences Financial Deals and Alliances 30
Benitec Biopharma Limited, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 30
Benitec Biopharma Limited, Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013 31
Benitec Biopharma Limited, Recent Deals Summary 32
Section 5 – Company’s Recent Developments 33
Benitec Biopharma Limited, Recent Developments 33
Oct 08, 2012: Benitec Biopharma Receives Notice Of Allowance For RNAi Expression Constructs In China 33
Feb 28, 2012: Benitec Biopharma Reports H1 Fiscal 2012 Results 33
Feb 06, 2012: Benitec Biopharma And Medistem Technologies Announce Successful Treatment Of Rheumatoid Arthritis In Preclinical Studies 33
Jan 09, 2012: Researchers Demonstrate Potential Of Benitec's ddRNAi Technology To Develop Revolutionary Therapeutics From Single Administration 34
Section 6 – Appendix 35
Methodology 35
Ratio Definitions 35
About GlobalData 39
Contact Us 39
Disclaimer 39

List of Tables
Benitec Biopharma Limited, Key Facts 5
Benitec Biopharma Limited, Key Employees 6
Benitec Biopharma Limited, Key Employee Biographies 7
Benitec Biopharma Limited, Major Products and Services 8
Benitec Biopharma Limited, Number of Pipeline Products by Therapy Area 9
Benitec Biopharma Limited, Number of Pipeline Products by Development Stage 10
Benitec Biopharma Limited, Pipeline Products By Therapy Area and Development Phase 11
Benitec Biopharma Limited, History 12
Benitec Biopharma Limited, Other Locations 17
Benitec Biopharma Limited, Subsidiaries 17
Benitec Biopharma Limited, Key Competitors 24
Benitec Biopharma Limited, Ratios based on current share price 25
Benitec Biopharma Limited, Annual Ratios 25
Benitec Biopharma Limited, Interim Ratios 28
Benitec Biopharma Limited, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 30
Benitec Biopharma Limited, Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013 31
Benitec Biopharma Limited, Recent Deals Summary 32
Currency Codes 35
Capital Market Ratios 35
Equity Ratios 36
Profitability Ratios 36
Cost Ratios 37
Liquidity Ratios 37
Leverage Ratios 38
Efficiency Ratios 38

List of Figures
Benitec Biopharma Limited, Pipeline Products by Therapy Area 9
Benitec Biopharma Limited, Pipeline Products by Development Phase 10
Benitec Biopharma Limited, Performance Chart (2008 - 2012) 27
Benitec Biopharma Limited, Ratio Charts 29
Benitec Biopharma Limited, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 30
Benitec Biopharma Limited, Pharmaceuticals & Healthcare, Deals by Type, 2007 to YTD 2013 31




...